Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.

Drugmaker Daiichi Sankyo has risen the most in five months after its novel breast cancer treatment won U.S. approval, a ...

Tokyo: Daichi Sankyo has announced that DATROWAY (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the ...

Sharni Marks agreed to have a double mastectomy after learning she had a high breast cancer risk but the operation came too ...

Questions about sex and intimacy often go unanswered for people with cancer. It's a glaring problem, especially for the ...

Kate's statement after he Royal Marsden Hospital visit resonated strongly with me. Like Kate, I am - touch wood - in ...

More than 200,000 young people have faced delays to cancer treatment in the last decade, according to figures seen exclusively by The Herald.

Precision medicine is a kind of personalized cancer care treatment where every cancer patient is treated differently.

Mary George, an Ayyappankavu resident, has not gone out much as she has been under treatment for breast and spine cancer.

"For example, if you are a male and your donor is a female and you do a blood DNA test your results will show that you are a ...

The Galleri test, developed by Grail, screens for over 50 types of cancer with a single blood draw. Despite its potential ...